VIVUS, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$13.6M
Doctors Paid
8,220
Transactions
24,079
2024 Total
$245,506
Payment Breakdown by Category
Research$9.5M (69.5%)
Royalty/License$3.0M (22.4%)
Consulting$487,593 (3.6%)
Food & Beverage$418,589 (3.1%)
Travel$43,998 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $9.5M | 1,239 | 69.5% |
| Royalty or License | $3.0M | 29 | 22.4% |
| Consulting Fee | $487,593 | 107 | 3.6% |
| Food and Beverage | $418,589 | 22,545 | 3.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $110,680 | 64 | 0.8% |
| Travel and Lodging | $43,998 | 71 | 0.3% |
| Charitable Contribution | $39,000 | 15 | 0.3% |
| Space rental or facility fees (teaching hospital only) | $12,050 | 6 | 0.1% |
| Education | $24.78 | 3 | 0.0% |
Payments by Type
Research
$9.5M
1,239 transactions
General
$4.2M
22,840 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Study of VI-0521 on Ambulatory Blood Pressure in Overweight or Obese Subject | $4.4M | 0 | 292 |
| A Phase IV Safety and Efficacy of VI-0521 in Obese Adolescents | $4.2M | 0 | 385 |
| IIT - Anti Obesity Pharmacotherapy vs Patients Using a Wearable Activity Tracker | $535,331 | 0 | 11 |
| IIT - Pancreaze Enzyme Replenishment Therapy | $262,040 | 0 | 6 |
| Long-term Study in US Cystic Fibrosis | $76,406 | 0 | 270 |
| Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms | $40,248 | 0 | 275 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2023 |
|---|---|---|---|---|
| Dr. Dinabel Peralta-Reich, M.d, M.D | Pediatrics | Valhalla, NY | $3,105 | $0 |
| Dr. Yevgeniy Mikityanskiy, D.o, D.O | Gastroenterology | Brooklyn, NY | $2,893 | $0 |
| Angela Fitch, Md, MD | Internal Medicine | Boston, MA | $2,863 | $0 |
| Steven Kawut, Md, MD | Internal Medicine | Philadelphia, PA | $2,800 | $0 |
| Dr. Michael Shanik, M.d, M.D | Endocrinology, Diabetes & Metabolism | Smithtown, NY | $2,717 | $0 |
| Dr. Hooman Poor, Md, MD | Student in an Organized Health Care Education/Training Program | New York, NY | $2,570 | $0 |
| Stephen Chan | Cardiovascular Disease | Pittsburgh, PA | $2,549 | $0 |
| Ashwini Gore, M.d, M.D | Endocrinology, Diabetes & Metabolism | Macon, GA | $2,174 | $0 |
| Dr. Amanda Powell, Md, MD | Internal Medicine | Burlington, MA | $2,023 | $0 |
| Michael Aikens, Md, MD | Cardiovascular Disease | Opelika, AL | $1,906 | $0 |
| Dr. Harold Pretorius, M.d, M.D | Nuclear Medicine | Cincinnati, OH | $1,877 | $0 |
| Dr. Anna Hemnes, Md, MD | Internal Medicine | Nashville, TN | $1,824 | $0 |
| Mitchell Krucoff, M.d, M.D | Cardiovascular Disease | Durham, NC | $1,600 | $0 |
| Lisa Myers, M.d, M.D | Endocrinology, Diabetes & Metabolism | Germantown, TN | $1,537 | $0 |
| Peter Kowey, Md, MD | Clinical Cardiac Electrophysiology | Wynnewood, PA | $1,500 | $0 |
| Dr. Edda Spiekerkoetter, M.d, M.D | Critical Care Medicine | Stanford, CA | $1,400 | $0 |
| David Reardon | Hematology & Oncology | Boston, MA | $1,400 | $0 |
| Eric Kodish, Md, MD | Pediatric Hematology-Oncology | Cleveland, OH | $1,375 | $0 |
| Jonathan Berek, Md, MD | Obstetrics & Gynecology | Stanford, CA | $1,000 | $0 |
| Ronnie Cyzner, M.d, M.D | Gastroenterology | Charlotte, NC | $945.60 | $0 |
| Angel Rosario, Md, MD | Internal Medicine | Tampa, FL | $829.08 | $0 |
| Patrick Wen, Md, MD | Neurology | Boston, MA | $800.00 | $0 |
| Stanley Fiel, Md, MD | Pulmonary Disease | Morristown, NJ | $800.00 | $0 |
| Robert Pampin, D.o, D.O | Family Medicine | Newton, NJ | $788.25 | $0 |
| Dr. Alexander Brun, Md, MD | Gastroenterology | Brooklyn, NY | $787.60 | $0 |
About VIVUS, Inc.
VIVUS, Inc. has made $13.6M in payments to 8,220 healthcare providers, recorded across 24,079 transactions in the CMS Open Payments database. In 2024, the company paid $245,506. The top product by payment volume is QSYMIA ($13.0M).
Payments were distributed across 128 medical specialties. The top specialty by payment amount is Cardiovascular Disease ($281,620 to 52 doctors).
Payment categories include: Food & Beverage ($418,589), Consulting ($487,593), Research ($9.5M), Travel & Lodging ($43,998), Royalties ($3.0M).
VIVUS, Inc. is associated with 4 products in the CMS Open Payments database, including QSYMIA, PANCREAZE, and Qsymia.